연구동향
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
207편 검색→189편 판독→93편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Prevalence and progression of monoclonal gammopathy of undetermined significance in older adults
Prevalence and progression of monoclonal gammopathy of undetermined significance in older adults출판 연도
선별된 93편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01follow-up · population-based37편
- 0.94
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
Kyle RA, Therneau TM, Rajkumar SV et al. · The New England journal of medicine · 2002
- 0.93
Monoclonal gammopathy in Iceland: a population-based registry and follow-up
Ogmundsdottir HM, Haraldsdottir V, M Johannesson G et al. · British journal of haematology · 2002
- 0.93
Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece
Anagnostopoulos A, Evangelopoulou A, Sotou D et al. · Annals of hematology · 2002
- 0.93
Monoclonal gammopathy of undetermined significance
Kyle RA · Blood reviews · 1994
- 0.92
Cabrera Q, Macro M, Hebert B et al. · Cancer epidemiology · 2014
- 0.91
Kyle RA, Rajkumar SV, Therneau TM et al. · Clinical lymphoma · 2005
- 0.88
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance
Sandecka V, Hajek R, Pour L et al. · European journal of haematology · 2017
- 0.88
Visram A, Larson D, Norman A et al. · Blood · 2025
- 0.87
El-Khoury H, Lee DJ, Alberge JB et al. · The Lancet. Haematology · 2022
- 0.87
Atkin C, Reddy-Kolanu V, Drayson MT et al. · British journal of haematology · 2020
- 0.86
Kang KW, Song JE, Lee BH et al. · Scientific reports · 2021
- 0.86
Kyle RA, Benson J, Larson D et al. · Clinical lymphoma & myeloma · 2009
- 0.85
Roman E, Bagguley T, Crouch S et al. · Haematologica · 2026
- 0.84
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance
Kyle RA, Therneau TM, Rajkumar SV et al. · Blood · 2003
- 0.84
Rognvaldsson S, Thorsteinsdottir S, Syriopoulou E et al. · Haematologica · 2024
- 0.84
Ma L, Xu S, Wen L et al. · Blood cells, molecules & diseases · 2018
- 0.83
Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study
Gupta R, Dahiya M, Kumar L et al. · Clinical lymphoma, myeloma & leukemia · 2018
- 0.81
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana
Landgren O, Katzmann JA, Hsing AW et al. · Mayo Clinic proceedings · 2007
- 0.80
Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
Pasqualetti P, Casale R · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 1997
- 0.79
Voigtlaender M, Vogler B, Trepel M et al. · Annals of hematology · 2015
- 0.79
Baldini L, Goldaniga M, Guffanti A et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2005
- 0.78
Dietary intake is associated with risk of multiple myeloma and its precursor disease
Thordardottir M, Lindqvist EK, Lund SH et al. · PloS one · 2018
- 0.78
Varettoni M, Corso A, Cocito F et al. · Medicine · 2010
- 0.75
Fracture risk in monoclonal gammopathy of undetermined significance
Melton LJ3, Rajkumar SV, Khosla S et al. · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2004
- 0.74
Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N, Schwarzler A, Gobel G et al. · Oncotarget · 2017
- 0.71
Lee JY, Jung EJ, Kwon S et al. · Haematologica · 2026
- 0.68
Rognvaldsson S, Thorsteinsdottir S, Eythorsson E et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
- 0.68
Rognvaldsson S, Aspelund T, Thorsteinsdottir S et al. · European journal of haematology · 2021
- 0.67
Jonsdottir AH, Sigurjonsdottir HA, Thorsteinsdottir S et al. · Blood · 2025
- 0.62
Eythorsson E, Rognvaldsson S, Thorsteinsdottir S et al. · Annals of internal medicine · 2024
- 0.60
Monoclonal gammopathy of undetermined significance
Kyle RA, Rajkumar SV · Clinical lymphoma & myeloma · 2005
- 0.54
Go RS, Gundrum JD, Neuner JM · Clinical lymphoma, myeloma & leukemia · 2015
- 0.54
Jou E, Gligich O, Chan ACY et al. · Hematological oncology · 2017
- 0.54
Cassez R, Cortet B, Bouvard B et al. · Archives of osteoporosis · 2026
- 0.52
Za T, De Stefano V, Rossi E et al. · British journal of haematology · 2013
- 0.52
Multimorbidity in patients with monoclonal gammopathy of undetermined significance
Epstein MM, Zhou Y, Castaneda-Avila MA et al. · International journal of cancer · 2023
- 0.50
Identifying monoclonal gammopathy of undetermined significance in electronic health data
Epstein MM, Saphirak C, Zhou Y et al. · Pharmacoepidemiology and drug safety · 2020
02survival · confidence interval19편
- 0.93
Long-term follow-up of a population based cohort with monoclonal proteinaemia
Schaar CG, le Cessie S, Snijder S et al. · British journal of haematology · 2009
- 0.90
Landgren O, Gridley G, Turesson I et al. · Blood · 2006
- 0.84
Dhodapkar MV, Sexton R, Hoering A et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
- 0.81
Chang SH, Luo S, Thomas TS et al. · Journal of the National Cancer Institute · 2017
- 0.81
Wang M, Sigel B, Liu L et al. · International journal of cancer · 2026
- 0.80
Liu L, Sigel B, Wang M et al. · Blood cancer journal · 2026
- 0.79
Cumulative Excess Body Mass Index and MGUS Progression to Myeloma
Liu L, Grandhi N, Wang M et al. · JAMA network open · 2025
- 0.78
Ko H, Choi S, Park SS et al. · ESMO open · 2025
- 0.78
Landgren O, Kyle RA, Pfeiffer RM et al. · Blood · 2009
- 0.75
Chang SH, Luo S, O'Brian KK et al. · The Lancet. Haematology · 2015
- 0.75
Zuern K, Hielscher T, Werly A et al. · Blood cancer journal · 2024
- 0.75
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
Visram A, Soof C, Rajkumar SV et al. · Blood cancer journal · 2021
- 0.72
Prognostic factors in monoclonal gammopathy of undetermined significance
Sackmann F, Pavlovsky MA, Corrado C et al. · Haematologica · 2008
- 0.66
Bumma N, Nagasaka M, Hemingway G et al. · Clinical lymphoma, myeloma & leukemia · 2020
- 0.61
GLP-1 receptor agonists in patients with MGUS: A real-world propensity-matched study
Tentolouris A, Ntanasis-Stathopoulos I, Filippatos C et al. · European journal of clinical investigation · 2026
- 0.59
Association and Prognostic Significance of Comorbidities in Individuals With MGUS
Bawek S, Nassour N, Alharbi M et al. · Clinical lymphoma, myeloma & leukemia · 2026
- 0.57
Hanamura I, Stewart JP, Huang Y et al. · Blood · 2006
- 0.54
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Kristinsson SY, Fears TR, Gridley G et al. · Blood · 2008
- 0.52
6q deletion in Waldenstrom macroglobulinaemia negatively affects time to transformation and survival
Garcia-Sanz R, Dogliotti I, Zaccaria GM et al. · British journal of haematology · 2021
03free light · chain13편
- 0.94
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Kyle RA, Larson DR, Therneau TM et al. · The New England journal of medicine · 2018
- 0.93
Eisele L, Durig J, Huttmann A et al. · Annals of hematology · 2012
- 0.92
Dispenzieri A, Katzmann JA, Kyle RA et al. · Lancet (London, England) · 2010
- 0.89
Pelzer BW, Arendt M, Moebus S et al. · Annals of hematology · 2018
- 0.89
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
Einarsson Long T, Rognvaldsson S, Thorsteinsdottir S et al. · JAMA oncology · 2025
- 0.88
Cherry BM, Costello R, Zingone A et al. · American journal of hematology · 2013
- 0.85
Landgren O, Hofmann JN, McShane CM et al. · JAMA oncology · 2019
- 0.83
Maeng CV, Rognvaldsson S, Einarsson Long T et al. · Blood cancer journal · 2025
- 0.83
Katzmann JA, Clark R, Kyle RA et al. · Leukemia · 2013
- 0.78
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification
Andersen LS, Maeng CV, Rognvaldsson S et al. · Blood cancer journal · 2026
- 0.59
de Fost M, Out TA, de Wilde FA et al. · Annals of hematology · 2008
- 0.52
Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression
Andrade-Campos M, Murillo-Florez I, Garcia-Sanz R et al. · Clinical chemistry and laboratory medicine · 2017
- 0.50
Greil C, Ihorst G, Gaiser F et al. · European journal of haematology · 2017
04detected · plasma cell10편
- 0.95
Therneau TM, Kyle RA, Melton LJ3 et al. · Mayo Clinic proceedings · 2012
- 0.89
Landgren O, Graubard BI, Katzmann JA et al. · Leukemia · 2014
- 0.89
Neriishi K, Nakashima E, Suzuki G · British journal of haematology · 2003
- 0.85
Varettoni M, Zibellini S, Boveri E et al. · British journal of haematology · 2019
- 0.84
Iwanaga M, Tagawa M, Tsukasaki K et al. · Blood · 2009
- 0.75
Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics
Clay-Gilmour AI, Kumar S, Rajkumar SV et al. · Leukemia · 2019
- 0.68
Monoclonal gammopathy in atomic bomb survivors
Neriishi K, Yoshimoto Y, Carter RL et al. · Radiation research · 1993
- 0.64
Varettoni M, Arcaini L, Zibellini S et al. · Blood · 2013
- 0.56
Ross FM, Chiecchio L, Dagrada G et al. · Haematologica · 2010
- 0.55
The incidence and epidemiology of plasma cell neoplasms
Bergsagel D · Stem cells (Dayton, Ohio) · 1995
05transplantation · kidney6편
- 0.83
Kuwabara C, Sakuma Y, Kume A et al. · International journal of hematology · 2019
- 0.73
Alfano G, Fontana F, Colaci E et al. · Transplantation · 2017
- 0.70
Bancu I, Canas L, Juega FJ et al. · Transplantation proceedings · 2015
- 0.65
Follow-up monoclonal gammopathy of undetermined significance in kidney transplant
Cuellar-Garcia C, Sevillano Ruiz-Mateos C, Mazuecos Blanca MA et al. · Transplantation proceedings · 2015
- 0.62
Naina HVK, Harris S, Dispenzieri A et al. · American journal of nephrology · 2012
- 0.58
Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
Aslam N, Trautman CL, Sher T · Transplantation direct · 2021
06expression · bone marrow6편
- 0.81
Castaneda-Avila MA, Lapane KL, Person SD et al. · Hematological oncology · 2022
- 0.77
Zhang C, Hou K, Lin D et al. · Clinical and experimental medicine · 2026
- 0.76
Jerez A, Ortuno FJ, Osma MDM et al. · Annals of medicine · 2009
- 0.60
Hofmann JN, Mailankody S, Korde N et al. · Obesity (Silver Spring, Md.) · 2017
- 0.59
Herdenberg S, Wibom C, Krop EJM et al. · Cancer prevention research (Philadelphia, Pa.) · 2025
- 0.53
Stella F, Pedrazzini E, Baialardo E et al. · Blood cells, molecules & diseases · 2014
07response · syndrome2편
- 0.85
Rosinol L, Cibeira MT, Montoto S et al. · Mayo Clinic proceedings · 2007
- 0.72
Clinical characteristics and outcomes in biclonal gammopathies
Mullikin TC, Rajkumar SV, Dispenzieri A et al. · American journal of hematology · 2016